Key Takeaways
- Daré Bioscience secures a grant of $385,000
- Funding boosts their ongoing efforts in innovative health care products development
- The grant is their 7th funding round, bringing total funding to $22,139,643
The biopharma startup Daré Bioscience, known for its commitment to the development and commercialization of innovative health care products, recently undergoes its 7th funding round. They successfully bagged a grant amounting to $385,000 on July 31, 2023.
The funding was led by The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has been particularly active in backing health care and biotech startups. With this recent grant, Daré Bioscience’s total funding now amounts to a significant $22,139,643.
This California-based startup is known in the Biopharma, Biotechnology, and Health Care industry for its significant efforts in setting new standards and continually reinventing health care solutions. As they receive this grant, Daré Bioscience is expected to ramp up their research and development activities at their location in La Jolla, California.
For more details about Daré Bioscience, their ongoing projects and their contact details, visit their website.
Ready to amplify your reach and engage with the most dynamic community in the venture world? Consider sponsoring an article with us. Learn more about our promotional opportunities and sponsored articles here.
Your story could be the next big hit on US Venture News!
Follow Us